Navigation Links
PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009
Date:10/27/2009

INCLINE VILLAGE, Nev., Oct. 27 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Oppenheimer 20th Annual Healthcare Conference in New York City on Wednesday, November 4, 2009 at 9:40 a.m. Eastern Time

To access the live and subsequently archived webcast of the conference call, go to the company's website at http://www.pdl.com and click "Investors." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. A replay will be available at www.pdl.com starting approximately three hours after completion of the webcast.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
4. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
5. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
6. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
7. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
8. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2013)... 2013  Stem cells have long been touted as the ... to Dr. Dennis Lox , some patients with a ... to stem cell therapy for aid. Avascular necrosis (AVN) also ... in which the blood supply to the bone becomes disrupted, ... to as necrosis. The region may be very painful, and ...
(Date:6/14/2013)... DIEGO , June 14, 2013  Mast Therapeutics, ... an underwritten public offering of 50,000,000 units, each unit ... common stock and one warrant to purchase 0.5 of ... price of $0.50 per unit.  The units will not ... stock and the warrants are immediately separable and will ...
(Date:6/14/2013)... Toronto, ON / Boston, MA (PRWEB) June 14, ... the world’s largest independent resource for life scientists ... new e-commerce features within the growing 1DegreeBio marketplace. ... quickly browse through hundreds of vendor catalogues, access ... create purchase orders, email products to lab managers ...
(Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...
Breaking Biology Technology:Stem Cells May Help Some With Avascular Necrosis (AVN) 2Mast Therapeutics Prices Public Offering Of Units 2Mast Therapeutics Prices Public Offering Of Units 3Mast Therapeutics Prices Public Offering Of Units 41DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform 2Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
... hardest substance in the human body is moved by its ... a schnitzel, enormous strengths are working on the surface of ... also goes for dentures, inlays or bridges", glass chemist Prof. ... (Germany) says. After all, these are worn as much as ...
... 2012 Tengion, Inc. (NASDAQ: TNGN ... it has completed the relocation of its corporate ... existing facility in Winston-Salem, North Carolina.  The relocation ... which was designed to fund the Company,s lead ...
... Jan. 5, 2012  Superior Controls, Inc. has been ... Control Engineering magazine.  Each year, the worldwide competition ... exceptional technical expertise, business skills and customer satisfaction. ... 50 applications from industrial systems integrators throughout the ...
Cached Biology Technology:Nanocrystals make dentures shine 2Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 2Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 3Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 4Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine 2
(Date:6/17/2013)... patients with severe brain infections in Vietnam. Further research ... for the symptoms of disease. , The virus was ... patients with severe brain infections in the study, corresponding ... 122 patients with non-infectious brain disorders that were tested. ... are often fatal and patients who do survive, often ...
(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...
(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...
Breaking Biology News(10 mins):New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3'Chemical architects' build materials with potential applications in drug delivery and gas storage 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2
... from the University of Exeter has revealed taking a dietary ... boost stamina during high-intensity exercise. The study has important ... can allow people to exercise up to 20% longer and ... comes on the back of previous research from Exeter which ...
... such as depression, anxiety disorders, addiction and schizophrenia are ... the world. In the EU alone, each year 27% ... 83 Million citizens suffer from mental disorders. Depression ... as the most disabling disorder of all diseases. Unless ...
... Nev. There is still much that is unknown ... Reno psychologist has added to the body of knowledge ... to demystify, prevent and treat the mysterious condition. ... assistant professor of psychology at the University of Nevada, ...
Cached Biology News:Supplement produces a 'striking' endurance boost 223rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 223rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 323rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 423rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 523rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 623rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 723rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 823rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 923rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 1023rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress 11University of Nevada professor studies structural basis for autism disorders 2
384 well block MBSr. Robot compatible block ejection mechanism. Stackable. (384 well block - holds 384 well plate)...
...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
... The MBS Satellite Thermal ... and flexible solution for medium ... The MBS combines the latest ... friendly software and PC control, ...
Biology Products: